JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

The Fontan Dapagliflozin Pilot Study

Phase 4

Conditions: Heart Failure

Interventions: Drug: Dapagliflozin 10mg Tab

First Posted Date: 2023-02-23

Last Posted Date: 2024-11-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 29

Registration Number: NCT05741658

Locations: 🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

Cerebellar Involvement in Alcohol Use Disorder (AUD)

Not Applicable

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Procedure: cerebellar transcranial direct current stimulation

First Posted Date: 2023-02-16

Last Posted Date: 2024-05-16

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 122

Registration Number: NCT05732207

Locations: 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Phase 2

Recruiting

Conditions: Coronary Microvascular Dysfunction
Metabolic Syndrome

Interventions: Drug: Vericiguat
Drug: Placebo

First Posted Date: 2023-02-03

Last Posted Date: 2024-05-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 45

Registration Number: NCT05711719

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Imaging the Pathogenesis of Cerebral Small Vessel Disease

Recruiting

Conditions: Hypertension
Ischemic Stroke
Hyperlipidemias
Diabetes

First Posted Date: 2023-01-30

Last Posted Date: 2024-02-08

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 50

Registration Number: NCT05703386

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Estrogen Supplementation and Bone Health in Women With CF

Phase 4

Recruiting

Conditions: Cystic Fibrosis
Hypoestrogenism

Interventions: Drug: Transdermal estrogen
Drug: Progesterone

First Posted Date: 2023-01-30

Last Posted Date: 2024-11-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 75

Registration Number: NCT05704036

Locations: 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant

Phase 1

Active, not recruiting

Conditions: Staphylococcus Aureus
Microbial Colonization
Neonatal Infection

Interventions: Biological: Placebo
Biological: nasal microbiota transplant (NMT)

First Posted Date: 2023-01-23

Last Posted Date: 2024-07-29

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 34

Registration Number: NCT05695196

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Recruiting

Conditions: Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)
Neurofibromatosis 1
Atypical Neurofibroma

First Posted Date: 2023-01-10

Last Posted Date: 2023-12-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 80

Registration Number: NCT05677594

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Vestibular Implantation in Older Adults

Not Applicable

Recruiting

Conditions: Bilateral Vestibulopathy
Sensation Disorders
Presbyvestibulopathy
Gentamicin Ototoxicity
Vestibular Diseases
Bilateral Vestibular Hypofunction
Other Disorders of Vestibular Function, Bilateral
Bilateral Vestibular Deficiency (BVD)
Labyrinth Diseases
Aminoglycoside Ototoxicity

Interventions: Device: Labyrinth Devices MVI™ Multichannel Vestibular Implant System

First Posted Date: 2023-01-09

Last Posted Date: 2024-02-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 15

Registration Number: NCT05676944

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

Not Applicable

Recruiting

Conditions: Bilateral Vestibular Deficiency (BVD)
Bilateral Vestibular Hypofunction
Bilateral Vestibulopathy
Gentamicin Ototoxicity
Labyrinth Diseases
Vestibular Diseases
Sensation Disorders
Other Disorders of Vestibular Function, Bilateral
Aminoglycoside Ototoxicity

Interventions: Device: Labyrinth Devices MVI™ Multichannel Vestibular Implant System

First Posted Date: 2023-01-06

Last Posted Date: 2024-02-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 8

Registration Number: NCT05674786

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Not Applicable

Recruiting

Conditions: Drug Resistant Tuberculosis

Interventions: Other: Nurse-Led Treatment in Primary Care

First Posted Date: 2023-01-05

Last Posted Date: 2024-10-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 2944

Registration Number: NCT05671718

Locations: 🇿🇦
Doris Goodwin Hospital, Pietermaritzburg, KwaZulu-Natal, South Africa
🇿🇦
Murchison Hospital, Port Shepstone, KwaZulu-Natal, South Africa
🇿🇦
King Dinuzulu TB Hospital, East London, South Africa

and more 2 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy